CG Results Healthcare has advised Novartis on its strategic alliance with BASF

CG Results Healthcare is delighted to have been the exclusive advisor to leading global medicines company Novartis, on its strategic alliance with BASF, the largest chemical producer in the world, and the first external company to become part of the Novartis Kundl/Schaftenau Life Science Park.

Novartis is further developing its campus in Kundl/Schaftenau by attracting companies from the life sciences sector. An attractive research and production location is being created that benefits from excellent, competitive production conditions in the heart of Europe and the immediate proximity to Switzerland, Italy and Germany.

BASF is the first external company to become part of the Life Science Park and at the same time an important player in the enzyme and biotechnology industry. BASF will invest in a world-scale plant for the production of bacterial enzymes and thus further expand the production of enzymes and biotech products at the site.

This transaction highlights CG Results Healthcare’s excellent sector knowledge and capability in providing advice on strategic options for both healthcare businesses and healthcare assets.